Evidence map›Paper›PMID 36992811›Full record

ReviewFrontiers in endocrinology2023

Regulation of the immune system by the insulin receptor in health and disease.

Priya Makhijani, Paulo José Basso, Yi Tao Chan, Nan Chen, Jordan Baechle, Saad Khan, David Furman, Sue Tsai, Daniel A Winer

Open access · goldFull text readReview
In one paragraph

Review in Frontiers in endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
16.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Insulin Resistance and Inflammation.International journal of molecular sciences · 2026
    Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Priya MakhijaniDepartment of Immunology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Paulo José BassoDepartment of Medical Microbiology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.
Yi Tao ChanTemerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Nan ChenDivision of Cellular and Molecular Biology, Diabetes Research Group, Toronto General Hospital Research Institute (TGHRI), University Health Network, Toronto, ON, Canada.
Jordan BaechleBuck Institute for Research in Aging, Novato, CA, United States.
Saad KhanDepartment of Immunology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
David FurmanBuck Institute for Research in Aging, Novato, CA, United States.
Sue TsaiDepartment of Medical Microbiology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.
Daniel A WinerDepartment of Immunology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
University of Toronto · CAUniversity of Alberta · CABuck Institute for Research on Aging · USConsejo Nacional de Investigaciones Científicas y Técnicas · ARToronto General Hospital · CA

Funding

Training in Basic Research on Aging and Age-Related DiseaseT32AG000266 · NIA · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI Lisa M Ellerby · 1998 to 2026
$13.8M
The B Cell Insulin Receptor in Health and in Insulin ResistanceR01DK128435 · NIDDK · BUCK INSTITUTE FOR RESEARCH ON AGING · PI Dan Winer · 2022 to 2026
$2.9M
NIA NIH HHS T32 AG000266NIDDK NIH HHS R01 DK128435
6 · The paper itself

Abstract

The signaling pathways downstream of the insulin receptor (InsR) are some of the most evolutionarily conserved pathways that regulate organism longevity and metabolism. InsR signaling is well characterized in metabolic tissues, such as liver, muscle, and fat, actively orchestrating cellular processes, including growth, survival, and nutrient metabolism. However, cells of the immune system also express the InsR and downstream signaling machinery, and there is increasing appreciation for the involvement of InsR signaling in shaping the immune response. Here, we summarize current understanding of InsR signaling pathways in different immune cell subsets and their impact on cellular metabolism, differentiation, and effector versus regulatory function. We also discuss mechanistic links between altered InsR signaling and immune dysfunction in various disease settings and conditions, with a focus on age related conditions, such as type 2 diabetes, cancer and infection vulnerability.

Indexed as

Diabetes Mellitus, Type 2Receptor, InsulinHumansImmune SystemInsulinSignal TransductionInsulinReceptor, Insulinagingcancerimmunometabolisminfectioninflammationinsulin resistanceobesitypre-eclampsia

Identifiers

PMID36992811
PMCPMC10040865
OpenAlexW4324088613

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read2
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.